Bee Venom Acupuncture for the Treatment of Frozen Shoulder

February 1, 2012 updated by: Yonghyeon Baek, Kyunghee University Medical Center

Randomized Controlled Double Blind Study of Bee Venom Therapy on Adhesive Capsulitis of the Shoulder

The purpose of this study is to evaluate the effectiveness of combined bee venom acupuncture (BVA) and physiotherapy (PT) on frozen shoulder, and whether if the effect of BVA is dose effective.

Study Overview

Study Type

Interventional

Enrollment (Actual)

68

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Seoul, Korea, Republic of, 134-727
        • Arthritis & Rheumatism Center, Kyung Hee University Hospital at Gangdong

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Diagnosis of frozen shoulder by orthopedist
  • Must have shoulder pain of more than VAS 5 over 1 month and under 12 months
  • Marked limitation of active and/or passive motion range in one shoulder

Exclusion Criteria:

  • history of major shoulder injury or surgery
  • other musculoskeletal pain
  • cervical neuropathy, paralysis, neurological disorder
  • hypersensitivity reactions by bee venom skin test
  • renal or hepatic disorders, hematologic diseases, cancer, mental disorders, inflammatory or infectious disorders

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: BV1
1:10,000 bee venom (BV) acupuncture plus physiotherapy

after skin test for hypersensitivity to bee venom (0.05ml of 1:30,000 bee venom, SC at LI11)

  • 1st visit : SC 0.4ml of 1:10,000 BV at 4 points (0.1ml for each points)
  • 2nd visit : SC 0.6ml of 1:10,000 BV at 6 points (0.1ml for each points)
  • 3rd visit : SC 0.8ml of 1:10,000 BV at 8 points (0.1ml for each points)
  • 4th to 16th visit : SC 1.0ml of 1:10,000 BV at 10 points (0.1ml for each points)

Physiotherapy treatment will be provided at each visit after bee venom or saline injection.

  • transcutaneous electrical nerve stimulation (TENS) for 15 minutes
  • transcutaneous infrared thermotherapy (TDP) for 15 minutes
  • manual physical therapy for 15 minutes
  • simple home exercise program
EXPERIMENTAL: BV2
1:30,000 bee venom (BV) acupuncture plus physiotherapy

Physiotherapy treatment will be provided at each visit after bee venom or saline injection.

  • transcutaneous electrical nerve stimulation (TENS) for 15 minutes
  • transcutaneous infrared thermotherapy (TDP) for 15 minutes
  • manual physical therapy for 15 minutes
  • simple home exercise program

after skin test for hypersensitivity to bee venom (0.05ml of 1:30,000 bee venom, SC at LI11)

  • 1st visit : SC 0.4ml of 1:30,000 BV at 4 points (0.1ml for each points)
  • 2nd visit : SC 0.6ml of 1:30,000 BV at 6 points (0.1ml for each points)
  • 3rd visit : SC 0.8ml of 1:30,000 BV at 8 points (0.1ml for each points)
  • 4th to 16th visit : SC 1.0ml of 1:30,000 BV at 10 points (0.1ml for each points)
PLACEBO_COMPARATOR: NS
Normal saline injection plus physiotherapy

Physiotherapy treatment will be provided at each visit after bee venom or saline injection.

  • transcutaneous electrical nerve stimulation (TENS) for 15 minutes
  • transcutaneous infrared thermotherapy (TDP) for 15 minutes
  • manual physical therapy for 15 minutes
  • simple home exercise program

after skin test for hypersensitivity to bee venom (0.05ml of 1:30,000 bee venom, SC at LI11)

  • 1st visit : SC 0.4ml of normal saline at 4 points (0.1ml for each points)
  • 2nd visit : SC 0.6ml of normal saline at 6 points (0.1ml for each points)
  • 3rd visit : SC 0.8ml of normal saline at 8 points (0.1ml for each points)
  • 4th to 16th visit : SC 1.0ml of normal saline at 10 points (0.1ml for each points)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
the Shoulder Pain and Disability Index (SPADI)
Time Frame: Changes from baseline in SPADI at 2, 4, 8, 12 weeks
Changes from baseline in SPADI at 2, 4, 8, 12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analogue Scale (VAS) for pain intensity
Time Frame: Changes from baseline in VAS at 2, 4, 8, 12 weeks
Changes from baseline in VAS at 2, 4, 8, 12 weeks
passive Range of Motion (pROM)
Time Frame: Changes from baseline in pROM at 2, 4, 8, 12 weeks
The 4 motions (abduction, forward flexion, extension, and external rotation) will be checked.
Changes from baseline in pROM at 2, 4, 8, 12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yonghyeon Baek, OMD, Ph.D, Kyung Hee University Hospital at Gangdong
  • Study Director: Byung-Kwan Seo, OMD, Ph.D, Kyung Hee University Hospital at Gangdong

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2010

Primary Completion (ACTUAL)

July 1, 2010

Study Completion (ACTUAL)

July 1, 2010

Study Registration Dates

First Submitted

February 1, 2012

First Submitted That Met QC Criteria

February 1, 2012

First Posted (ESTIMATE)

February 3, 2012

Study Record Updates

Last Update Posted (ESTIMATE)

February 3, 2012

Last Update Submitted That Met QC Criteria

February 1, 2012

Last Verified

February 1, 2012

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • KHNMC-OH-IRB 2009-013

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Frozen Shoulder

Clinical Trials on 1:10,000 bee venom (BV) acupuncture

Subscribe